RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
6.2M
Position Mix
No options reported
Reported Value
$1.3B
Portfolio Weight
25.38%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$5.0B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
6.2M
Position Mix
No options reported
Reported Value
$1.3B
Portfolio Weight
25.38%
GMAB
Depositary ReceiptGENMAB A/S
Reported Shares
14.1M
Position Mix
No options reported
Reported Value
$504.3M
Portfolio Weight
10.03%
EWTX
Common StockEdgewise Therapeutics, Inc.
Reported Shares
10.8M
Position Mix
No options reported
Reported Value
$437.6M
Portfolio Weight
8.70%
SYRE
Common StockSpyre Therapeutics, Inc.
Reported Shares
4.5M
Position Mix
No options reported
Reported Value
$396.8M
Portfolio Weight
7.89%
INSM
Common StockINSMED Inc
Reported Shares
2.7M
Position Mix
No options reported
Reported Value
$307.7M
Portfolio Weight
6.12%
MBX
Common StockMBX Biosciences, Inc.
Reported Shares
3.8M
Position Mix
No options reported
Reported Value
$221.2M
Portfolio Weight
4.40%
ORKA
Common StockOruka Therapeutics, Inc.
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$207.7M
Portfolio Weight
4.13%
BLTE
Depositary ReceiptBELITE BIO, INC
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$194.0M
Portfolio Weight
3.86%
TARS
Common StockTarsus Pharmaceuticals, Inc.
Reported Shares
2.3M
Position Mix
No options reported
Reported Value
$180.9M
Portfolio Weight
3.60%
TNGX
Common StockTango Therapeutics, Inc.
Reported Shares
7M
Position Mix
No options reported
Reported Value
$173.7M
Portfolio Weight
3.45%
VRDN
Common StockViridian Therapeutics, Inc.\DE
Reported Shares
8.3M
Position Mix
No options reported
Reported Value
$170.0M
Portfolio Weight
3.38%
BBIO
Common StockBridgeBio Pharma, Inc.
Reported Shares
2.3M
Position Mix
No options reported
Reported Value
$154.5M
Portfolio Weight
3.07%
PCVX
Common StockVaxcyte, Inc.
Reported Shares
2.1M
Position Mix
No options reported
Reported Value
$121.9M
Portfolio Weight
2.42%
ERAS
Common StockErasca, Inc.
Reported Shares
8M
Position Mix
No options reported
Reported Value
$117.3M
Portfolio Weight
2.33%
JBIO
Common StockJade Biosciences, Inc.
Reported Shares
6.1M
Position Mix
No options reported
Reported Value
$85.0M
Portfolio Weight
1.69%
TYRA
Common StockTyra Biosciences, Inc.
Reported Shares
3.5M
Position Mix
No options reported
Reported Value
$76.8M
Portfolio Weight
1.53%
OLMA
Common StockOlema Oncology, Inc.
Reported Shares
8.7M
Position Mix
No options reported
Reported Value
$75.3M
Portfolio Weight
1.50%
OBX
Common StockObsidian Therapeutics, Inc.
Reported Shares
4.2M
Position Mix
No options reported
Reported Value
$57.1M
Portfolio Weight
1.13%
GPCR
Depositary ReceiptStructure Therapeutics Inc.
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$40.6M
Portfolio Weight
0.81%
ACHV
Common StockACHIEVE LIFE SCIENCES, INC.
Reported Shares
5M
Position Mix
No options reported
Reported Value
$40.1M
Portfolio Weight
0.80%